Breaking News
Get 40% Off 0
🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought it Read More
Close

ADBiotech Co Ltd (179530)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3,055 -195    -6.00%
16:19:53 - Real-time Data. Currency in KRW ( Disclaimer )
  • Volume: 194,856
  • Bid/Ask: 3,040 / 3,055
  • Day's Range: 2,995 - 3,255
Type:  Equity
Market:  South Korea
ISIN:  KR7179530001 
ADBiotech 3,055 -195 -6.00%

179530 Balance Sheet

 
Featured here, the Balance Sheet for ADBiotech Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 8698.8 13417.38 8695.66 10086.28
Cash and Short Term Investments 3831.58 9413.87 4171.26 5823.59
Cash - - - -
Cash & Equivalents 3201.58 3014.77 2471.26 3789.02
Short Term Investments 630 630 1700 2034.57
Total Receivables, Net 1751.84 1604.36 1609.75 1217.2
Accounts Receivables - Trade, Net 1571.56 1596.3 1552.72 1145.71
Total Inventory 2873.63 2264.68 2668.59 2696.03
Prepaid Expenses 32.48 16.83 127.12 165.39
Other Current Assets, Total 209.27 117.63 118.95 184.07
Total Assets 22896.22 28093.23 30461.64 32156.93
Property/Plant/Equipment, Total - Net 10093.28 10311.76 10287.88 10497.6
Property/Plant/Equipment, Total - Gross 10093.28 10311.76 10287.88 10497.6
Accumulated Depreciation, Total - - - -
Goodwill, Net 1126.41 1126.41 4192.81 4192.81
Intangibles, Net 996.43 1029.18 48.91 51.06
Long Term Investments 1857.74 1584.99 6345.84 6485.69
Note Receivable - Long Term 180.28 8.07 57.03 71.49
Other Long Term Assets, Total 123.56 623.51 183.25 150.97
Other Assets, Total 1961.07 7177.05 3585.08 4389.98
Total Current Liabilities 11005.93 11268.07 11070.97 13518.44
Accounts Payable 540.51 250.65 414.34 351.93
Payable/Accrued - - - -
Accrued Expenses 133.62 212.78 253.22 236
Notes Payable/Short Term Debt 8034.9 9142.4 9013.05 10271.8
Current Port. of LT Debt/Capital Leases 722.71 488.46 247.73 245.22
Other Current liabilities, Total 1574.18 1173.78 1142.63 2413.48
Total Liabilities 14965.48 15524.56 15308.97 16979.87
Total Long Term Debt 3681.63 3979.24 3995.44 3258.99
Long Term Debt 3238.84 3513 3687.16 2928.8
Capital Lease Obligations 442.8 466.24 308.28 330.19
Deferred Income Tax 198.93 205.32 - -
Minority Interest -2786.87 -2545.43 -1196.17 -860.53
Other Liabilities, Total -5169.05 -6525.05 -7574.32 -9208.82
Total Equity 7930.75 12568.67 15152.67 15177.06
Redeemable Preferred Stock, Total 1721.56 1721.56 1634.87 396.11
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 4570.22 4570.22 4570.22 4570.22
Additional Paid-In Capital 27257.38 27257.38 27261.53 27267.75
Retained Earnings (Accumulated Deficit) -20676.67 -16431.38 -15145.48 -14198.33
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -4941.74 -4549.11 -3168.47 -2858.69
Total Liabilities & Shareholders' Equity 22896.22 28093.23 30461.64 32156.93
Total Common Shares Outstanding 9.14 9.14 9.14 9.14
Total Preferred Shares Outstanding - - - -
* In Millions of KRW (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

179530 Comments

Write your thoughts about ADBiotech Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email